CDR2L antibody (C-Term)
-
- Target See all CDR2L products
- CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))
-
Binding Specificity
- C-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This CDR2L antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogen
- CDR2 L antibody was raised in rabbit using the C terminal of CDR2 as the immunogen
-
-
- Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
CDR2L Blocking Peptide, catalog no. 33R-9763, is also available for use as a blocking control in assays to test for specificity of this CDR2L antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))
- Alternative Name
- CDR2L (CDR2L Products)
- Synonyms
- HUMPPA antibody, D030068L24Rik antibody, Gm21 antibody, fj58a11 antibody, wu:fj58a11 antibody, zgc:77462 antibody, RGD1306881 antibody, cerebellar degeneration related protein 2 like antibody, cerebellar degeneration-related protein 2-like antibody, CDR2L antibody, Cdr2l antibody, cdr2l antibody
- Background
- The function of CDR2L remains unknown. Synonyms: Polyclonal CDR2L antibody, Anti-CDR2L antibody, cerebellar degeneration-related protein 2-like antibody, HUMPPA antibody.
-